COP vs OGEN
ConocoPhillips (COP) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the COP and OGEN stock pages for the full models.
Not investment advice.